{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:46:39Z","timestamp":1777905999581,"version":"3.51.4"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background  Burden of disease is an indicator that relates to health status. United States and European epidemiological data have shown that the burden of chronic liver disease has increased significantly in recent decades. There are no studies evaluating the impact of complications of chronic liver disease on the waiting list for deceased donor liver transplantation (LTx).  Objective:  To determine the clinical and economic burden of complications of liver disease in wait-listed patients from the perspective of a transplant center.  Methods  The study retrospectively analyzed medical records of 104 patients wait-listed for deceased donor LTx from October 2012 to May 2016 and whose treatment was fully provided at the study transplant center. Clinical data were obtained from electronic medical records, while economic data were collected from a hospital management software. To allocate all direct medical costs, two methods were used: full absorption costing and micro-costing.  Results: The most common complication was refractory ascites (20.2%), followed by portosystemic encephalopathy (12.5%). The mean number of admissions per patient was 1.37\u00b13.42. Variceal hemorrhage was the complication with longest median length of stay (18 days), followed by hepatorenal syndrome (13.5 days). Hepatorenal syndrome was the costliest complication (mean cost of $3,565), followed by portosystemic encephalopathy ($2,576) and variceal hemorrhage ($1,530).  Conclusion: The burden of chronic liver disease includes a great cost for health systems. In addition, it is likely to be even greater as a result of the insidious course of the disease.<\/jats:p>","DOI":"10.1590\/s0004-2803.202204000-87","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:24:58Z","timestamp":1668439498000},"source":"Crossref","is-referenced-by-count":2,"title":["WAITING LIST FOR LIVER TRANSPLANTATION: CLINICAL AND ECONOMIC BURDEN"],"prefix":"10.1590","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-3622","authenticated-orcid":false,"given":"Santiago","family":"RODR\u00cdGUEZ","sequence":"first","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil; Hospital Vozandes,  Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9544-4699","authenticated-orcid":false,"given":"Fabio Da","family":"MOTTA","sequence":"additional","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8289-1932","authenticated-orcid":false,"given":"Gi\u00e1como","family":"BALBINOTTO NETO","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil; Instituto de Avalia\u00e7\u00f5es de Tecnologias e Sa\u00fade,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8411-5654","authenticated-orcid":false,"given":"Aj\u00e1cio","family":"BRAND\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brasil; Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.cgh.2015.08.015","article-title":"Current and future burden of chronic nonmalignant liver disease","volume":"13","author":"Udompap P","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.08.045","article-title":"Burden of gastrointestinal, liver, and pancreatic diseases in the United States","volume":"149","author":"Peery AF","year":"2015","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier M","year":"2013","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1665-2681(19)32086-1","article-title":"Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data","volume":"4","author":"M\u00e9ndez-S\u00e1nchez N","year":"2005","journal-title":"Ann Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/liv.12470","article-title":"Burden of liver disease in Brazil","volume":"34","author":"Nader LA","year":"2014","journal-title":"Liver Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico G","year":"2006","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","article-title":"Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis","volume":"63","author":"Bernardi M","year":"2015","journal-title":"J Hepatol"},{"key":"ref9","series-title":"Introdu\u00e7\u00e3o \u00e0 Farmacoeconomia","first-page":"31","volume-title":"Medindo e estimando custos","author":"Rascati KL","year":"2010"},{"key":"ref10","series-title":"Fundamentos de custos e m\u00e9todos de custos. In: Ching HY, editor. Manual de custos de institui\u00e7\u00f5es de sa\u00fade","first-page":"15","author":"Ching HY","year":"2001"},{"key":"ref11","series-title":"Evaluaci\u00f3n econ\u00f3mica de medicamentos y tecnolog\u00edas sanitarias","author":"Soto \u00c1lvarez J","year":"2012"},{"key":"ref12","series-title":"Sistemas de custeio aplicados \u00e0 gest\u00e3o de custos hospitalares. In: de Mattos AJ, editor. Gest\u00e3o de Custos hospitalares t\u00e9cnicas, an\u00e1lise e tomada de decis\u00e3o","first-page":"98","author":"De Mattos AJ","year":"2005"},{"key":"ref13","series-title":"Cost-effectiveness in health and medicine","author":"Gold MR","year":"1996"},{"key":"ref14","series-title":"S\u00e9rie Gest\u00e3o e Economia da Sa\u00fade","volume-title":"Introdu\u00e7\u00e3o \u00e0 gest\u00e3o de custos em sa\u00fade","volume":"Vol 2","year":"2013"},{"key":"ref15","series-title":"Methods for the Economic Evaluation of Health Care Programs","author":"Drummond M","year":"2005","edition":"3rd ed"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm E","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"ref18","first-page":"1","article-title":"Deaths: Final Data for 2013","volume":"64","author":"Xu J","year":"2016","journal-title":"Natl Vital Stat Rep"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch FX","year":"2004","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin DM","year":"2001","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2007.02.001","article-title":"Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome","volume":"46","author":"Arroyo V","year":"2007","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos \u00c2Z","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref23","series-title":"Research Portfolio Online Reporting Tools. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC)","year":"2022"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau R","year":"2013","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin SK","year":"2009","journal-title":"Hepatol Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj JS","year":"2014","journal-title":"Hepatology"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Lista de espera para transplante hep\u00e1tico: impacto cl\u00ednico e econ\u00f4mico"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032022005001204&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:25:17Z","timestamp":1668439517000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032022005001204&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":26,"alternative-id":["S0004-28032022005001204"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202204000-87","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}